Abstract
Safety and Efficacy of Ruxolitinib for the Final Enrollment of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (N = 2233)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have